Camrelizumab vs Placebo in Combination With Chemotherapy as Neoadjuvant Treatment in Patients With Early or Locally Advanced Triple-Negative Breast Cancer
2024 · JAMA · 35 citations
https://doi.org/10.1001/jama.2024.23560
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
91
Papers
1.8K
Citations
24
h-index
39
i10-index
Jun Qian is an academic researcher from Zhejiang Chinese Medical University. The author has contributed to research in topics: Radioactive element chemistry and processing & Chemical Synthesis and Characterization & Advanced X-ray Imaging Techniques. The author has an h-index of 24, co-authored 78 publications.
ORCID: 0000-0001-7546-9506https://doi.org/10.1001/jama.2024.23560
https://doi.org/10.1016/j.catcom.2023.106748
Click to start Chat